Anthropic physicists Liam Fitzpatrick and Siddharth Mishra-Sharma used Claude Fable 5.1 to compute the nine-loop scattering amplitude in N=4 super Yang-Mills theory for roughly $1,000–$2,000 on 96 CPU…
Anthropic announced last Tuesday that roughly 950 parallel Claude agents, running for 21 hours on 210 million tokens, identified a previously unknown three-part enzyme system it calls Array-Associated…
Anthropic researchers used the company's Claude Science platform to solve an outstanding problem in physicist and freelance writer 4gravitons' former research field, after reading his August 7, 2026 b…
Anthropic has established a physical biology wet lab in the San Francisco Bay Area, extending its life-sciences work beyond software and simulations into hands-on experimental research. According to R…
Anthropic is building a biology lab in the San Francisco area where its Claude model will guide robots through drug experiments with minimal human involvement, Reuters reported. The lab builds on Anth…
Novo Nordisk is deploying Anthropic's Claude Science model directly into its drug research and development workflows, according to CIO.com, as part of a strategy to become the most AI-driven healthcar…
Anthropic has established a physical "wet lab" for hands-on biological experiments in the San Francisco Bay Area, a move confirmed by Eric Kauderer-Abrams, Anthropic's head of life sciences, who told …
Anthropic has established physical biology wet labs and hired bench scientists to let its Claude models conduct real-world drug discovery experiments, targeting rare and neglected diseases. The initia…
Anthropic introduced the Life Sciences Verification Program (LSVP), a beta program granting verified life science teams access to its Mythos, Opus, and Sonnet models with safeguards that are more perm…
Novo, the Danish pharmaceutical company formerly known as Novo Nordisk, announced a strategic partnership with Anthropic on September 16 to deploy Anthropic's Claude models and the Claude Science work…
Novo, the Danish pharmaceutical company formerly known as Novo Nordisk, announced Wednesday a partnership with Anthropic to use Anthropic's models and Claude Science to advance AI-driven drug discover…
Novo Nordisk is partnering with Anthropic to apply Claude Science and other AI models to drug discovery, the companies said in a Sept. 16 statement. Novo Nordisk will test Claude Science on selected R…
Novo, the Danish pharmaceutical company formerly known as Novo Nordisk, announced a partnership with Anthropic to use the AI company's models and Claude Science in its drug research, with Novo CEO Mik…
NVIDIA and Anthropic have integrated the NVIDIA BioNeMo Agent Toolkit into Claude Science, enabling AI agents to run protein structure prediction with multiple-sequence alignment using NVIDIA NIM micr…
Anthropic is offering its Claude Team plan free for 12 months to 10,000 scientists at academic and nonprofit research institutions, with verified principal investigators qualifying for a free Standard…
Anthropic announced it is opening 10,000 seats for scientists worldwide to access Claude subscriptions for free or at discounted rates for one year through its new Claude team plan for scientists, wit…
Anthropic announced on August 27 that it is releasing 10,000 Claude subscription seats for scientists, offering free standard access or premium seats at $15 per month for a year, and expanding its AI …
Anthropic released Claude Science, a desktop app for macOS and Linux that wraps its existing Claude models (including Opus 4.8) in persistent Python and R kernels, 60-plus database connectors, and HPC…
Claude AI, developed by Anthropic, autonomously designed 1,320 protein binders, of which 354 were lab-validated, achieving a 26.8% average hit rate across 14 of 15 targets, according to Adaptyv Bio. T…
Anthropic reported that its Claude AI system autonomously designed de novo protein binders with a 27% experimental hit rate across most targets tested, using the new Claude Science platform launched o…